Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2018 call → NOWe need to determine if management's forward account consists of narrating what its counterparties are themselves doing and scaling, such that the company's own coming volume is presented as a consequence of those parties' own trajectories. We need to check the transcript for instances where management describes specific customers, partners, etc., their own growth, and that the company is already inside that growth, and that the trajectory is early and large. Look for examples: In the transcript, management discusses various segments. For instance, in RF Technology, they mention Deltek, freight matching, CBORD, toll and traffic, etc. They talk about wins, but not necessarily about counterparties' own scaling. They mention "large wins" but not that the counterparties are themselves expanding. In Medical & Scientific Imaging, they mention Verathon's new technology, GlideScope consumables, etc. Not about counterparties scaling. In Industrial Technology, they mention Neptune, Cornell Pump, Roper Pump. They talk about market share gains, but not about specific customers' own build-outs. In Energy, they mention upstream applications, Compressor Controls returning to growth. The key is whether management's forward account is dominated by reporting on the growth of specific counterparties that the company already supplies, and that those counterparties are in early stages of large expansions. Look for specific mentions: For example, in the toll and traffic part, they mention the New York project, but that's a project they managed, not necessarily a counterparty scaling. They mention Saudi, but not as a scaling counterparty. They mention "our freight matching business" and "significant adds in net subscribers" - that's about their own business, not counterparties. They mention "customer service centers" and "winning more business" - that's about their own selling. They mention "PowerPlan" acquisition, but that's about the acquired company's business, not about counterparties scaling. They mention "ConstructConnect" building muscle, but that's their own. They mention "Gatan" divestiture, but that's about the business itself. The question is specifically about management narrating what its counterparties are themselves doing and scaling.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.